New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
07:13 EDTDCTHDelcath Systems announces reimbursement for Chemostat in Chermany
Delcath Systems announced that the Institut für das Entgeltsystem im Krankenhaus, the German federal reimbursement agency, has established a reimbursement pathway for the treatment of patients with liver metastases with the Delcath Hepatic CHEMOSAT Delivery System for melphalan hydrochloride. The Value 4 status given to the CHEMOSAT procedure, while not mandating reimbursement, allows participating cancer centers to negotiate reimbursement coverage for the CHEMOSAT procedure with all insurers serving their region. Under the NUB scheme, reimbursement pathways will potentially be available for treatment with CHEMOSAT regardless of primary cancer origin.
News For DCTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
08:34 EDTDCTHDelcath Systems' Chemosat issued reimbursement coverage in Germany
Subscribe for More Information
October 7, 2015
17:19 EDTDCTHDelcath Systems files $77.4M mixed securities shelf
Subscribe for More Information
September 30, 2015
08:04 EDTDCTHDelcath Systems' Chemosat for liver metastases shows efficacy in two studies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use